Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Mirum Pharmaceuticals, Inc.MIRM · Entity 2416 | SVP, GLOBAL CONTROLLER | September 02, 2026 | September 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Mirum Pharmaceuticals, Inc.
Report date September 02, 2026 · Filed September 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 616 |
Reported balance
After 2026-09-02 transaction · row 1
1 source rowRow 1 · 2026-09-02 · Sale · Disposed 658 · Balance 616 F1: Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 18, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 18, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 02, 2026 Filed Sep 3, 2026 22:54 UTC | Mirum Pharmaceuticals, Inc. MIRM · Entity 2416 | SaleCommon Stock | 658 | $100.00 | $65,800.00 |
DisclosureSEC source: 0001974200-26-000013 · form4-09032026_100913.xml · nonDerivative · entry 1 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 616 F1 · kind: Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 18, 2026. Read SEC document |
| August 18, 2026 Filed Aug 19, 2026 22:19 UTC | Mirum Pharmaceuticals, Inc. MIRM · Entity 2416 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 40,000 | $0.00 Strike: $6.27 | $0.00 |
DisclosureSEC source: 0001974200-26-000012 · form4-08192026_100826.xml · derivative · entry 3 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 40,000 shares Expires 2029-05-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock option is fully vested. Read SEC document |
| August 18, 2026 Filed Aug 19, 2026 22:19 UTC | Mirum Pharmaceuticals, Inc. MIRM · Entity 2416 | SaleCommon Stock | 40,000 | $100.00 | $4,000,000.00 |
DisclosureSEC source: 0001974200-26-000012 · form4-08192026_100826.xml · nonDerivative · entry 2 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,274 Read SEC document |
| August 18, 2026 Filed Aug 19, 2026 22:19 UTC | Mirum Pharmaceuticals, Inc. MIRM · Entity 2416 | Exercise / conversionCommon Stock | 40,000 | $6.27 | $250,800.00 |
DisclosureSEC source: 0001974200-26-000012 · form4-08192026_100826.xml · nonDerivative · entry 1 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,274 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 03, 2026 Filed Aug 5, 2026 20:26 UTC | Mirum Pharmaceuticals, Inc. MIRM · Entity 2416 | SaleCommon Stock | 1,840 | $105.29 | $193,733.60 |
DisclosureSEC source: 0001974200-26-000011 · form4-08052026_080847.xml · nonDerivative · entry 1 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,274 F1 · kind: Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 18, 2026. Read SEC document |
| July 01, 2026 Filed Jul 2, 2026 22:01 UTC | Mirum Pharmaceuticals, Inc. MIRM · Entity 2416 | SaleCommon Stock | 2,721 | $120.00 | $326,520.00 |
DisclosureSEC source: 0001974200-26-000010 · form4-07022026_100751.xml · nonDerivative · entry 1 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,114 F1 · kind: Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 18, 2026. Read SEC document |
| June 17, 2026 Filed Jun 18, 2026 22:39 UTC | Mirum Pharmaceuticals, Inc. MIRM · Entity 2416 | SaleCommon Stock | 2,594 | $101.95 | $264,458.30 |
DisclosureSEC source: 0001974200-26-000009 · form4-06182026_100638.xml · nonDerivative · entry 1 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,835 F1 · kind: Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 18, 2026. Read SEC document |
| March 16, 2026 Filed Mar 17, 2026 23:30 UTC | Mirum Pharmaceuticals, Inc. MIRM · Entity 2416 | SaleCommon Stock | 4,732 | $91.98 | $435,239.42 |
DisclosureSEC source: 0001974200-26-000008 · form4-03172026_070304.xml · nonDerivative · entry 3 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,429 F2 · kind: Shares sold to cover tax withholding obligations associated with the vesting of the performance restricted stock units. Read SEC document |
| March 15, 2026 Filed Mar 17, 2026 23:30 UTC | Mirum Pharmaceuticals, Inc. MIRM · Entity 2416 | Exercise / conversionPerformance Restricted Stock Units · Derivative | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001974200-26-000008 · form4-03172026_070304.xml · derivative · entry 5 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock · 6,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each performance restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F4 · derivative.exercise_date: The shares vest as follows: 2/3 of the shares vest on March 15, 2026 and 1/3 of the shares vest on March 15, 2027. F4 · derivative.expiration_date: The shares vest as follows: 2/3 of the shares vest on March 15, 2026 and 1/3 of the shares vest on March 15, 2027. Read SEC document |
| March 15, 2026 Filed Mar 17, 2026 23:30 UTC | Mirum Pharmaceuticals, Inc. MIRM · Entity 2416 | Exercise / conversionPerformance Restricted Stock Units · Derivative | 2,658 | $0.00 | $0.00 |
DisclosureSEC source: 0001974200-26-000008 · form4-03172026_070304.xml · derivative · entry 4 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,658 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each performance restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: The shares vest as follows: 2/3 of the shares vest on March 15, 2025 and 1/3 of the shares vest on March 15, 2026. F3 · derivative.expiration_date: The shares vest as follows: 2/3 of the shares vest on March 15, 2025 and 1/3 of the shares vest on March 15, 2026. Read SEC document |
| March 15, 2026 Filed Mar 17, 2026 23:30 UTC | Mirum Pharmaceuticals, Inc. MIRM · Entity 2416 | Exercise / conversionCommon Stock | 6,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001974200-26-000008 · form4-03172026_070304.xml · nonDerivative · entry 2 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,161 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each performance restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| March 15, 2026 Filed Mar 17, 2026 23:30 UTC | Mirum Pharmaceuticals, Inc. MIRM · Entity 2416 | Exercise / conversionCommon Stock | 2,658 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001974200-26-000008 · form4-03172026_070304.xml · nonDerivative · entry 1 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,161 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each performance restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| February 02, 2026 Filed Feb 4, 2026 02:45 UTC | Mirum Pharmaceuticals, Inc. MIRM · Entity 2416 | SaleCommon Stock | 968 | $103.30 | $99,997.79 |
DisclosureSEC source: 0001974200-26-000006 · form4-02032026_090202.xml · nonDerivative · entry 2 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,503 F2 · kind: Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units. Read SEC document |
| January 31, 2026 Filed Feb 4, 2026 02:45 UTC | Mirum Pharmaceuticals, Inc. MIRM · Entity 2416 | Exercise / conversionRestricted Stock Units · Derivative | 1,771 | $0.00 | $0.00 |
DisclosureSEC source: 0001974200-26-000006 · form4-02032026_090202.xml · derivative · entry 3 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,771 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer). F3 · derivative.exercise_date: The restricted stock units vest in a series of three successive equal annual installments beginning January 31, 2024. 1,772 shares vested on January 31, 2024 ; 1,772 shares vested January 31, 2025 and the remaining 1,771 shares will vest on January 31, 2026. F3 · derivative.expiration_date: The restricted stock units vest in a series of three successive equal annual installments beginning January 31, 2024. 1,772 shares vested on January 31, 2024 ; 1,772 shares vested January 31, 2025 and the remaining 1,771 shares will vest on January 31, 2026. Read SEC document |
| January 31, 2026 Filed Feb 4, 2026 02:45 UTC | Mirum Pharmaceuticals, Inc. MIRM · Entity 2416 | Exercise / conversionCommon Stock | 1,771 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001974200-26-000006 · form4-02032026_090202.xml · nonDerivative · entry 1 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,471 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer). Read SEC document |
| January 28, 2026 Filed Jan 30, 2026 23:30 UTC | Mirum Pharmaceuticals, Inc. MIRM · Entity 2416 | GrantPerformance Restricted Stock Units · Derivative | 9,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001974200-26-000004 · form4-01302026_060108.xml · derivative · entry 3 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,000 Underlying: Common Stock · 9,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F4 · derivative.exercise_date: On January 23, 2024, the reporting person was granted performance restricted stock units ("PSUs") which vest upon satisfaction of certain performance criteria. On January 28, 2026, performance criteria were determined to have been met. The shares subject to the PSUs vest as follows: 2/3 of the shares vest on March 15, 2026 and 1/3 of the shares vest on March 15, 2027. F4 · derivative.expiration_date: On January 23, 2024, the reporting person was granted performance restricted stock units ("PSUs") which vest upon satisfaction of certain performance criteria. On January 28, 2026, performance criteria were determined to have been met. The shares subject to the PSUs vest as follows: 2/3 of the shares vest on March 15, 2026 and 1/3 of the shares vest on March 15, 2027. Read SEC document |
| January 28, 2026 Filed Jan 30, 2026 23:30 UTC | Mirum Pharmaceuticals, Inc. MIRM · Entity 2416 | GrantRestricted Stock Units · Derivative | 4,970 | $0.00 | $0.00 |
DisclosureSEC source: 0001974200-26-000004 · form4-01302026_060108.xml · derivative · entry 2 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,970 Underlying: Common Stock · 4,970 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: 1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 28, 2026 (the "Vesting Commencement Date"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date. F3 · derivative.expiration_date: 1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 28, 2026 (the "Vesting Commencement Date"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date. Read SEC document |
| January 28, 2026 Filed Jan 30, 2026 23:30 UTC | Mirum Pharmaceuticals, Inc. MIRM · Entity 2416 | GrantStock Option (right to buy) · Derivative | 7,680 | $0.00 Strike: $100.85 | $0.00 |
DisclosureSEC source: 0001974200-26-000004 · form4-01302026_060108.xml · derivative · entry 1 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,680 Underlying: Common Stock · 7,680 shares Expires 2036-01-27 F1 · derivative.exercise_date: 1/4th of the shares vest one year after January 28, 2026 (the "Vesting Commencement Date") and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date. Read SEC document |
| January 26, 2026 Filed Jan 27, 2026 21:30 UTC | Mirum Pharmaceuticals, Inc. MIRM · Entity 2416 | SaleCommon Stock | 842 | $96.19 | $80,993.66 |
DisclosureSEC source: 0001974200-26-000002 · form4-01272026_040105.xml · nonDerivative · entry 2 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,700 F2 · kind: Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units. Read SEC document |
| January 23, 2026 Filed Jan 27, 2026 21:30 UTC | Mirum Pharmaceuticals, Inc. MIRM · Entity 2416 | Exercise / conversionRestricted Stock Units · Derivative | 1,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001974200-26-000002 · form4-01272026_040105.xml · derivative · entry 3 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,500 Underlying: Common Stock · 1,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer). F3 · derivative.exercise_date: 1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 23, 2024 (the "Vesting Commencement Date"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date. F3 · derivative.expiration_date: 1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 23, 2024 (the "Vesting Commencement Date"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date. Read SEC document |
| January 23, 2026 Filed Jan 27, 2026 21:30 UTC | Mirum Pharmaceuticals, Inc. MIRM · Entity 2416 | Exercise / conversionCommon Stock | 1,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001974200-26-000002 · form4-01272026_040105.xml · nonDerivative · entry 1 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,542 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer). Read SEC document |
| January 22, 2026 Filed Jan 23, 2026 22:30 UTC | Mirum Pharmaceuticals, Inc. MIRM · Entity 2416 | SaleCommon Stock | 926 | $93.33 | $86,419.14 |
DisclosureSEC source: 0001974200-26-000001 · form4-01232026_050110.xml · nonDerivative · entry 2 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,042 F2 · kind: Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units. Read SEC document |
| January 21, 2026 Filed Jan 23, 2026 22:30 UTC | Mirum Pharmaceuticals, Inc. MIRM · Entity 2416 | Exercise / conversionRestricted Stock Units · Derivative | 1,542 | $0.00 | $0.00 |
DisclosureSEC source: 0001974200-26-000001 · form4-01232026_050110.xml · derivative · entry 3 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,083 Underlying: Common Stock · 1,542 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer). F3 · derivative.exercise_date: 1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 21, 2025 (the "Vesting Commencement Date"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date. F3 · derivative.expiration_date: 1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 21, 2025 (the "Vesting Commencement Date"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date. Read SEC document |
| January 21, 2026 Filed Jan 23, 2026 22:30 UTC | Mirum Pharmaceuticals, Inc. MIRM · Entity 2416 | Exercise / conversionCommon Stock | 1,542 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001974200-26-000001 · form4-01232026_050110.xml · nonDerivative · entry 1 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,968 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer). Read SEC document |
| August 07, 2025 Filed Aug 8, 2025 20:50 UTC | Mirum Pharmaceuticals, Inc. MIRM · Entity 2416 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $6.27 | $0.00 |
DisclosureSEC source: 0001415889-25-021351 · form4-08082025_080836.xml · derivative · entry 3 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 10,000 shares Expires 2029-05-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option is fully vested. Read SEC document |
| August 07, 2025 Filed Aug 8, 2025 20:50 UTC | Mirum Pharmaceuticals, Inc. MIRM · Entity 2416 | SaleCommon Stock | 10,000 | $58.00 | $580,000.00 |
DisclosureSEC source: 0001415889-25-021351 · form4-08082025_080836.xml · nonDerivative · entry 2 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,426 F1 · kind: Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on December 16, 2024. Read SEC document |
| August 07, 2025 Filed Aug 8, 2025 20:50 UTC | Mirum Pharmaceuticals, Inc. MIRM · Entity 2416 | Exercise / conversionCommon Stock | 10,000 | $6.27 | $62,700.00 |
DisclosureSEC source: 0001415889-25-021351 · form4-08082025_080836.xml · nonDerivative · entry 1 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,426 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 03, 2025 Filed Jul 3, 2025 22:48 UTC | Mirum Pharmaceuticals, Inc. MIRM · Entity 2416 | SaleCommon Stock | 477 | $49.08 | $23,411.16 |
DisclosureSEC source: 0001415889-25-019378 · form4-07032025_100743.xml · nonDerivative · entry 3 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,426 F3 · kind: Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on December 16, 2024. Read SEC document |
| July 02, 2025 Filed Jul 3, 2025 22:48 UTC | Mirum Pharmaceuticals, Inc. MIRM · Entity 2416 | SaleCommon Stock | 564 | $48.25 | $27,213.00 |
DisclosureSEC source: 0001415889-25-019378 · form4-07032025_100743.xml · nonDerivative · entry 2 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,903 F2 · kind: Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units. Read SEC document |
| July 01, 2025 Filed Jul 3, 2025 22:48 UTC | Mirum Pharmaceuticals, Inc. MIRM · Entity 2416 | Exercise / conversionRestricted Stock Units · Derivative | 1,041 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-019378 · form4-07032025_100743.xml · derivative · entry 4 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,041 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer). F4 · derivative.exercise_date: The restricted stock units vest in a series of three successive equal annual installments beginning July 1, 2023. F4 · derivative.expiration_date: The restricted stock units vest in a series of three successive equal annual installments beginning July 1, 2023. Read SEC document |
| July 01, 2025 Filed Jul 3, 2025 22:48 UTC | Mirum Pharmaceuticals, Inc. MIRM · Entity 2416 | Exercise / conversionCommon Stock | 1,041 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-25-019378 · form4-07032025_100743.xml · nonDerivative · entry 1 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 3,467 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer). Read SEC document |
| March 18, 2025 Filed Mar 19, 2025 21:40 UTC | Mirum Pharmaceuticals, Inc. MIRM · Entity 2416 | SaleCommon Stock | 2,415 | $44.45 | $107,342.89 |
DisclosureSEC source: 0001415889-25-008608 · form4-03192025_090306.xml · nonDerivative · entry 1 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,426 F1 · kind: Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on December 16, 2024. F2 · price: The weighted average sale price for the transaction reported was $44.448421, and the range of prices were between $44.21 and $44.91. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided. Read SEC document |
| March 17, 2025 Filed Mar 19, 2025 01:30 UTC | Mirum Pharmaceuticals, Inc. MIRM · Entity 2416 | Exercise / conversionStock Option (right to buy) · Derivative | 52,900 | $0.00 Strike: $2.94 | $0.00 |
DisclosureSEC source: 0001415889-25-008558 · form4-03182025_090306.xml · derivative · entry 8 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 52,900 shares Expires 2029-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: The stock option is fully vested. Read SEC document |
| March 17, 2025 Filed Mar 19, 2025 01:30 UTC | Mirum Pharmaceuticals, Inc. MIRM · Entity 2416 | SaleCommon Stock | 1,806 | $44.36 | $80,112.72 |
DisclosureSEC source: 0001415889-25-008558 · form4-03182025_090306.xml · nonDerivative · entry 6 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,841 F3 · kind: Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on December 16, 2024. F6 · price: The weighted average sale price for the transaction reported was $44.35923, and the range of prices were between $43.81 and $44.71. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided. Read SEC document |
| March 17, 2025 Filed Mar 19, 2025 01:30 UTC | Mirum Pharmaceuticals, Inc. MIRM · Entity 2416 | SaleCommon Stock | 2,789 | $44.75 | $124,802.45 |
DisclosureSEC source: 0001415889-25-008558 · form4-03182025_090306.xml · nonDerivative · entry 5 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,647 F3 · kind: Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on December 16, 2024. F5 · price: The weighted average sale price for the transaction reported was $44.74811, and the range of prices were between $44.70 and $44.84. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided. Read SEC document |
| March 17, 2025 Filed Mar 19, 2025 01:30 UTC | Mirum Pharmaceuticals, Inc. MIRM · Entity 2416 | SaleCommon Stock | 50,111 | $44.33 | $2,221,626.09 |
DisclosureSEC source: 0001415889-25-008558 · form4-03182025_090306.xml · nonDerivative · entry 4 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,436 F3 · kind: Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on December 16, 2024. F4 · price: The weighted average sale price for the transaction reported was $44.33410, and the range of prices were between $43.695 and $44.695. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided. Read SEC document |
| March 17, 2025 Filed Mar 19, 2025 01:30 UTC | Mirum Pharmaceuticals, Inc. MIRM · Entity 2416 | Exercise / conversionCommon Stock | 52,900 | $2.94 | $155,526.00 |
DisclosureSEC source: 0001415889-25-008558 · form4-03182025_090306.xml · nonDerivative · entry 3 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 59,547 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 17, 2025 Filed Mar 19, 2025 01:30 UTC | Mirum Pharmaceuticals, Inc. MIRM · Entity 2416 | SaleCommon Stock | 2,900 | $44.21 | $128,221.47 |
DisclosureSEC source: 0001415889-25-008558 · form4-03182025_090306.xml · nonDerivative · entry 2 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,647 F2 · kind: Shares sold to cover tax withholding obligations associated with the vesting of the performance restricted stock units. Read SEC document |
| March 15, 2025 Filed Mar 19, 2025 01:30 UTC | Mirum Pharmaceuticals, Inc. MIRM · Entity 2416 | Exercise / conversionPerformance Restricted Stock Units · Derivative | 5,315 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-008558 · form4-03182025_090306.xml · derivative · entry 7 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,658 Underlying: Common Stock · 5,315 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each performance restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F7 · derivative.exercise_date: The shares vest as follows: 2/3 of the shares vest on March 15, 2025 and 1/3 of the shares vest on March 15, 2026. F7 · derivative.expiration_date: The shares vest as follows: 2/3 of the shares vest on March 15, 2025 and 1/3 of the shares vest on March 15, 2026. Read SEC document |
| March 15, 2025 Filed Mar 19, 2025 01:30 UTC | Mirum Pharmaceuticals, Inc. MIRM · Entity 2416 | Exercise / conversionCommon Stock | 5,315 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-25-008558 · form4-03182025_090306.xml · nonDerivative · entry 1 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,547 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each performance restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| February 03, 2025 Filed Feb 4, 2025 22:30 UTC | Mirum Pharmaceuticals, Inc. MIRM · Entity 2416 | SaleCommon Stock | 1,064 | $48.22 | $51,308.74 |
DisclosureSEC source: 0001415889-25-002980 · form4-02042025_050201.xml · nonDerivative · entry 2 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,232 F2 · kind: Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 22:30 UTC | Mirum Pharmaceuticals, Inc. MIRM · Entity 2416 | Exercise / conversionRestricted Stock Units · Derivative | 1,772 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-002980 · form4-02042025_050201.xml · derivative · entry 3 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,771 Underlying: Common Stock · 1,772 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer). F3 · derivative.exercise_date: The restricted stock units vest in a series of three successive equal annual installments beginning January 31, 2024. 1,772 shares vested on January 31, 2024 ; 1,772 shares vested January 31, 2025 and the remaining 1,771 shares will vest on January 31, 2026. F3 · derivative.expiration_date: The restricted stock units vest in a series of three successive equal annual installments beginning January 31, 2024. 1,772 shares vested on January 31, 2024 ; 1,772 shares vested January 31, 2025 and the remaining 1,771 shares will vest on January 31, 2026. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 22:30 UTC | Mirum Pharmaceuticals, Inc. MIRM · Entity 2416 | Exercise / conversionCommon Stock | 1,772 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-25-002980 · form4-02042025_050201.xml · nonDerivative · entry 1 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,296 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer). Read SEC document |
| January 24, 2025 Filed Jan 27, 2025 21:48 UTC | Mirum Pharmaceuticals, Inc. MIRM · Entity 2416 | SaleCommon Stock | 902 | $47.92 | $43,227.81 |
DisclosureSEC source: 0001415889-25-002135 · form4-01272025_090147.xml · nonDerivative · entry 2 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,524 F2 · kind: Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units. Read SEC document |
| January 23, 2025 Filed Jan 27, 2025 21:48 UTC | Mirum Pharmaceuticals, Inc. MIRM · Entity 2416 | Exercise / conversionRestricted Stock Units · Derivative | 1,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-002135 · form4-01272025_090147.xml · derivative · entry 3 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,000 Underlying: Common Stock · 1,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer). F3 · derivative.exercise_date: 1/3rd of the shares subject to the restricted stock units vest on each anniversary of January 23, 2024 (the "Vesting Commencement Date"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date. F3 · derivative.expiration_date: 1/3rd of the shares subject to the restricted stock units vest on each anniversary of January 23, 2024 (the "Vesting Commencement Date"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date. Read SEC document |
| January 23, 2025 Filed Jan 27, 2025 21:48 UTC | Mirum Pharmaceuticals, Inc. MIRM · Entity 2416 | Exercise / conversionCommon Stock | 1,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-25-002135 · form4-01272025_090147.xml · nonDerivative · entry 1 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,426 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer). Read SEC document |
| January 21, 2025 Filed Jan 23, 2025 22:56 UTC | Mirum Pharmaceuticals, Inc. MIRM · Entity 2416 | GrantPerformance Restricted Stock Units · Derivative | 7,973 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-001955 · form4-01232025_100106.xml · derivative · entry 3 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,973 Underlying: Common Stock · 7,973 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F4 · derivative.exercise_date: On January 31, 2023, the reporting person was granted performance restricted stock units ("PSUs") which vest upon satisfaction of certain performance criteria. On January 21, 2025, performance criteria were determined to have been met. The shares subject to the PSUs vest as follows: 2/3 of the shares vest on March 15, 2025 and 1/3 of the shares vest on March 15, 2026. F4 · derivative.expiration_date: On January 31, 2023, the reporting person was granted performance restricted stock units ("PSUs") which vest upon satisfaction of certain performance criteria. On January 21, 2025, performance criteria were determined to have been met. The shares subject to the PSUs vest as follows: 2/3 of the shares vest on March 15, 2025 and 1/3 of the shares vest on March 15, 2026. Read SEC document |
| January 21, 2025 Filed Jan 23, 2025 22:56 UTC | Mirum Pharmaceuticals, Inc. MIRM · Entity 2416 | GrantRestricted Stock Units · Derivative | 4,625 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-001955 · form4-01232025_100106.xml · derivative · entry 2 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,625 Underlying: Common Stock · 4,625 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: 1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 21, 2025 (the "Vesting Commencement Date"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date. F3 · derivative.expiration_date: 1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 21, 2025 (the "Vesting Commencement Date"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date. Read SEC document |
| January 21, 2025 Filed Jan 23, 2025 22:56 UTC | Mirum Pharmaceuticals, Inc. MIRM · Entity 2416 | GrantStock Option (right to buy) · Derivative | 18,500 | $0.00 Strike: $47.98 | $0.00 |
DisclosureSEC source: 0001415889-25-001955 · form4-01232025_100106.xml · derivative · entry 1 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,500 Underlying: Common Stock · 18,500 shares Expires 2035-01-20 F1 · derivative.exercise_date: 1/4th of the shares vest one year after January 21, 2025 (the "Vesting Commencement Date") and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date. Read SEC document |
| January 07, 2025 Filed Jan 8, 2025 21:38 UTC | Mirum Pharmaceuticals, Inc. MIRM · Entity 2416 | SaleCommon Stock | 750 | $42.82 | $32,111.48 |
DisclosureSEC source: 0001415889-25-001142 · form4-01082025_090147.xml · nonDerivative · entry 2 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,926 F2 · kind: Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.